Outcome predictors of gamma knife surgery for melanoma brain metastases: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 3, 2011, Pages 769-779

  Liew, Donald N ^a   Kano, Hideyuki ^a   Kondziolka, Douglas ^a   Mathieu, David ^b   Niranjan, Ajay ^a   Flickinger, John C ^a   Kirkwood, John M ^a   Tarhini, Ahmad ^a   Moschos, Stergios ^a   Lunsford, L Dade ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Brain metastasis; Gamma knife; Hemorrhage; Melanoma; Stereotactic radiosurgery

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; INTERLEUKIN 2;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CRANIOTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RECURSIVE PARTITIONING ANALYSIS; SCORE INDEX OF RADIOSURGERY; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR BLEEDING; WHOLE BRAIN RADIATION THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952264449     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.5.JNS1014     Document Type: Article

References (54)

1. Atkins MB, Sosman JA, Agarwala S, Logan T, Clark JI, Ernstoff MS, et al: Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study. Cancer 113:2139-2145, 2008
2. Bafaloukos D, Gogas H: The treatment of brain metastases in melanoma patients. Cancer Treat Rev 30:515-520, 2004 (Pubitemid 39157852)
3. Bamias A, Aravantinos G, Deliveliotis C, Bafaloukos D, Kalofonos C, Xiros N, et al: Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group. J Clin Oncol 22:220-228, 2004 (Pubitemid 41095085)
4. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD: Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64:898-903, 2006 (Pubitemid 43183591)
5. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL: Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 62 Suppl 2:790-801, 2008
6. Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH: Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 94:2265-2272, 2002 (Pubitemid 34411986)
7. Chang EL, Selek U, Hassenbusch SJ III, Maor MH, Allen PK, Mahajan A, et al: Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery 56:936-945, 2005
8. Christopoulou A, Retsas S, Kingsley D, Paddick I, Lindquist C: Integration of gamma knife surgery in the management of cerebral metastases from melanoma. Melanoma Res 16:51-57, 2006 (Pubitemid 44133051)
9. DiLuna ML, King JT Jr, Knisely JP, Chiang VL: Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer 109:135-145, 2007 (Pubitemid 46127203)
10. Doss LL, Memula N: The radioresponsiveness of melanoma. Int J Radiat Oncol Biol Phys 8:1131-1134, 1982 (Pubitemid 12053187)
11. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247, 2009
12. Ellerhorst J, Strom E, Nardone E, McCutcheon I: Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 49:93-97, 2001 (Pubitemid 32041280)
13. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, et al: Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22:1293-1300, 2004 (Pubitemid 41079844)
14. Gaudy-Marqueste C, Regis JM, Muracciole X, Laurans R, Richard MA, Bonerandi JJ, et al: Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 65:809-816, 2006 (Pubitemid 43795850)
15. Geara FB, Ang KK: Radiation therapy for malignant melanoma. Surg Clin North Am 76:1383-1398, 1996 (Pubitemid 27010043)
16. Gieger M, Wu JK, Ling MN, Wazer D, Tsai JS, Engler MJ: Response of intracranial melanoma metastases to stereotactic radiosurgery. Radiat Oncol Investig 5:72-80, 1997 (Pubitemid 27323506)
17. Grooms GA, Eilber FR, Morton DL: Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients. J Surg Oncol 9:147-153, 1977 (Pubitemid 8092320)
18. Guirguis LM, Yang JC, White DE, Steinberg SM, Liewehr DJ, Rosenberg SA, et al: Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastases. J Immunother 25:82-87, 2002 (Pubitemid 34052838)
19. Hara W, Tran P, Li G, Su Z, Puataweepong P, Adler JR Jr, et al: Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Neurosurgery 64 (2 Suppl):A26-A32, 2009
20. Herfarth KK, Izwekowa O, Thilmann C, Pirzkall A, Delorme S, Hofmann U, et al: Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients. Strahlenther Onkol 179:366-371, 2003 (Pubitemid 36693259)
21. Jensen RL, Shrieve AF, Samlowski W, Shrieve DC: Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery. Clin Neurosurg 55:150-159, 2008
22. Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N, Gahbauer RA: Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 71:307-313, 2005 (Pubitemid 40372962)
23. Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, et al: Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 67:852-857, 1987 (Pubitemid 18005530)
24. Korn EL, Liu PY, Lee SJ, Chapman JA, Niedzwiecki D, Suman VJ, et al: Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 26:527-534, 2008 (Pubitemid 351264344)
25. Kouvaris JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous XN, et al: Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30:361-366, 2007 (Pubitemid 47013372)
26. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795-803, 1999 (Pubitemid 29152652)
27. Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O'Day SJ, et al: Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 44:59-66, 1999 (Pubitemid 29016167)
28. Lorenzoni J, Devriendt D, Massager N, David P, Ruíz S, Vanderlinden B, et al: Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218-224, 2004 (Pubitemid 39165488)
29. Manon R, O'Neill A, Knisely J, Werner-Wasik M, Lazarus HM, Wagner H, et al: Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 23:8870-8876, 2005 (Pubitemid 46211534)
30. Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, et al: Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery 60:471-482, 2007
31. Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, et al: Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 27:145-149, 2004 (Pubitemid 38621604)
32. Mingione V, Oliveira M, Prasad D, Steiner M, Steiner L: Gamma surgery for melanoma metastases in the brain. J Neurosurg 96:544-551, 2002 (Pubitemid 34230210)
33. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD: Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581-589, 1998 (Pubitemid 28501108)
34. Noël G, Simon JM, Valery CA, Cornu P, Boisserie G, Ledu D, et al: Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 79:245-255, 2002 (Pubitemid 36928775)
35. Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, et al: Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma. Chemotherapy 55:221-227, 2009
36. Powell JW, Chung CT, Shah HR, Canute GW, Hodge CJ, Bassano DA, et al: Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg 109 Suppl:122-128, 2008
37. Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, et al: Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 101:825-833, 2004 (Pubitemid 39030941)
38. Redmond AJ, Diluna ML, Hebert R, Moliterno JA, Desai R, Knisely JP, et al: Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg 109 Suppl:99-105, 2008
39. Saha S, Meyer M, Krementz ET, Hoda S, Carter RD, Muchmore J, et al: Prognostic evaluation of intracranial metastasis in malignant melanoma. Ann Surg Oncol 1:38-44, 1994
40. Samlowski WE, Watson GA, Wang M, Rao G, Klimo P Jr, Boucher K, et al: Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 109:1855-1862, 2007
41. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88:11-20, 1998 (Pubitemid 28018958)
42. Savas B, Arslan G, Gelen T, Karpuzoglu G, Ozkaynak C: Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy. Anticancer Res 19 (5C):4413-4420, 1999 (Pubitemid 30042799)
43. Selek U, Chang EL, Hassenbusch SJ III, Shiu AS, Lang FF, Allen P, et al: Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 59:1097-1106, 2004 (Pubitemid 38834303)
44. Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, et al: Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 4:103-109, 1998 (Pubitemid 29090714)
45. Sin AH, Cardenas RJ, Vannemreddy P, Nanda A: Gamma Knife stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers: outcome analysis of survival and control of brain disease. South Med J 102:42-44, 2009
46. Sloan AE, Nock CJ, Einstein DB: Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 16:248-255, 2009
47. Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 79:661-666, 1993 (Pubitemid 23320882)
48. Tarhini AA, Agarwala SS: Management of brain metastases in patients with melanoma. Curr Opin Oncol 16:161-166, 2004 (Pubitemid 38402531)
49. Tarhini AA, Kirkwood JM, Gooding WE, Moschos S, Agarwala SS: A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma. Cancer 113:1632-1640, 2008
50. Tsao H, Atkins MB, Sober AJ: Management of cutaneous melanoma. N Engl J Med 351:998-1012, 2004
51. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, et al: Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46:1155-1161, 2000 (Pubitemid 30139425)
52. Wroński M, Arbit E: Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 93:9-18, 2000 (Pubitemid 30457317)
53. Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, et al: Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 52:1277-1287, 2002 (Pubitemid 34296488)
54. Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G: Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96:552-558, 2002 (Pubitemid 34230211)